EUCLID SYSTEMS ORTHOKERATOLOGY (OPRIFOCON A) CONTACT LENS FOR OVERNIGHT WEAR

Lens, Contact, Orthokeratology, Overnight

FDA Premarket Approval P010062

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the euclid systems orthokeratology (oprifocon a) contact lenses for overnight wear. The lenses are indicated for use in the reduction of myopic refractive error in non-diseased eyes. The lenses are indicated for overnight wear for the temporary reduction of myopia up to 5. 00 diopters with eyes having astigmatism up to 1. 50 diopters. The lenses may only be disinfected using a chemical disinfection system. Note: to maintain the orthokeratology effect of myopia reduction, overnight lens wear must be continued on a prescribed schedule. Failure to do so can affect daily activities (e. G. , night driving), visual fluctuations and changes in intended correction.

DeviceEUCLID SYSTEMS ORTHOKERATOLOGY (OPRIFOCON A) CONTACT LENS FOR OVERNIGHT WEAR
Classification NameLens, Contact, Orthokeratology, Overnight
Generic NameLens, Contact, Orthokeratology, Overnight
ApplicantBAUSCH & LOMB
Date Received2001-10-26
Decision Date2004-06-07
Notice Date2004-06-14
PMAP010062
SupplementS
Product CodeNUU
Docket Number04M-0260
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address BAUSCH & LOMB 1400 North Goodman St. rochester, NY 14603-0450
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P010062Original Filing
S011 2018-05-25 Real-time Process
S010 2016-06-27 30-day Notice
S009 2011-05-31 30-day Notice
S008 2010-10-20 Normal 180 Day Track No User Fee
S007 2009-10-13 Normal 180 Day Track No User Fee
S006 2008-01-31 Real-time Process
S005 2006-12-21 Real-time Process
S004 2006-01-27 135 Review Track For 30-day Notice
S003 2005-04-18 Normal 180 Day Track No User Fee
S002 2004-09-01 Real-time Process
S001 2004-07-06 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.